Indication (pathologie):
Diabetes type
Identifiant SNOMED-CT:
SCTID 405751000
Etudes cliniques
-
ULB Center for Diabetes Research (UCDR) Biobank ProtocolRecrutement: Ouvert
-
Impact of exercise training on body composition, cardio-respiratory function, glycemic control and β cell function/survival according to diabetes etiologyIndication (pathologie):Diabetes typeIdentifiant SNOMED-CT:SCTID 405751000Recrutement: Ouvert
-
Apport de l’échographie et de la cytologie dans le bilan d’un nodule thyroïdien chaudIndication (pathologie):Thyroid noduleIdentifiant SNOMED-CT:SCTID 237495005Recrutement: Ouvert
-
A double-blind, placebo-controlled, randomized trial to determine the safety and efficacy of EMA401 100 mg b.i.d. in reducing 24-hour average pain intensity score in patients with painful diabetic neuropathyIndication (pathologie):Chronic painful diabetic neuropathyIdentifiant SNOMED-CT:SCTID 193184006Phase de l'étude: Phase IIRecrutement: Ouvert
-
Hypoparathyroïdie: traitement et qualité de vieIndication (pathologie):HypoparathyroidismIdentifiant SNOMED-CT:36976004Recrutement: Ouvert
-
Impact of exercise training on body composition, cardio-respiratory function, glycemic control and β cell function/survival according to diabetes etiology.Indication (pathologie):Diabetes mellitus etiologyIdentifiant SNOMED-CT:59079001Recrutement: Ouvert
-
Apport de l’échographie et de la cytologie dans le bilan d’un nodule thyroïdien chaudIndication (pathologie):Thyroid noduleIdentifiant SNOMED-CT:237495005Recrutement: Ouvert
-
A double-blind, placebo-controlled, randomized trial to determine the safety and efficacy of EMA401 100 mg b.i.d. in reducing 24-hour average pain intensity score in patients with painful diabetic neuropathyIndication (pathologie):Diabetic neuropathyIdentifiant SNOMED-CT:230572002Indication (pathologie):Acute painful diabetic neuropathyIdentifiant SNOMED-CT:193183000Phase de l'étude: Phase IIRecrutement: Ouvert
-
A double-blind, placebo-controlled, randomized trial to determine the safety and efficacy of EMA401 100mg b.i.d. in reducing 24 hour average pain intensity score in patients with painful diabetic neuropathy (EMPADINE)Indication (pathologie):Neuropathie diabétiqueIdentifiant SNOMED-CT:230572002Phase de l'étude: Phase IIRecrutement: Ouvert
-
Prospective, single arm, open-label, multicenter, international study to assess the effects of metyrapone in patients with endogenous Cushing's syndrome during a 12-week treatment period followed by an extension period of 24 weeksIndication (pathologie):Syndrome de CushingIdentifiant SNOMED-CT:47270006Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A multicenter, randomized, double blind, placebo controlled trial to evaluate the effects of dapaglifozin 10mg once daily on the incidence of cardiovascular death, myocardial infarction or ischemic stroke in patients with type 2 diabetes (Dapagliflozin effect on cardiovascular events )Indication (pathologie):Diabète sucré de type 2Identifiant SNOMED-CT:44054006Phase de l'étude: Phase IIIRecrutement: Fermé
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes MellitusIndication (pathologie):Diabète sucré de type 2Identifiant SNOMED-CT:44054006Phase de l'étude: Phase IIIRecrutement: Fermé
-
Etude randomisée en simple aveugle contrôlée par placebo chez des patients diabétiques de type 1 pour évaluer la sécurité, la tolérance, la pharmacodynamique, la pharmacocinétique d'une dose unique croissante et de doses répétées d'otelixizumabIndication (pathologie):Diabète sucré de type 1Identifiant SNOMED-CT:46635009Recrutement: Ouvert
-
Retrospective data collection on primary adrenal insufficiency in BelgiumIndication (pathologie):Insuffisance surrénalienneIdentifiant SNOMED-CT:386584007Recrutement: Ouvert
-
Etudes d'intervention nutritionnelle visant à prouver l'impact santé de l'apport en nutriments coliques (consommation de légumes et/ou supplémentation en fibres prébiotiques) chez les patients obèses et chez les sujets sainsIndication (pathologie):ObésitéIdentifiant SNOMED-CT:414916001Recrutement: Ouvert
-
DiaType - Personalized medicine in diabetes: towards an etiology-based diagnosis and better patient careIndication (pathologie):DiabèteIdentifiant SNOMED-CT:405751000Recrutement: Ouvert
-
INNODIA - An innovative approach towards understanding and arresting type 1 diabetesIndication (pathologie):Diabète de type 1Identifiant SNOMED-CT:46635009Recrutement: Ouvert